Executive Brief

The Potential Return on Investment of Using ePros Over Paper in Clinical Trials

ePRO vs. paper: that is the question. Download this latest report to learn more about the cost and
patient benefits to using ePRO versus paper.

Studies show that electronic patient reporting yields higher quality data than paper-based diaries and that electronic patient reported outcomes (ePROs) drive greater participant compliance. With our behavioral science-driven platform, compliance rates are consistently above 90% and retention rates are above 85% in our client’s clinical trials. For the past decade, both the FDA and EMA have begun to accept ePRO study data, and the number of trials using both electronic data capture (EDC) and ePRO has grown steadily. Despite these advances and the general use of technology in every part of our lives, some clinical trials continue to use paper-based questionnaires.

Unlock this free executive brief.

To access this executive brief, please complete the short form below.

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]